Suzuken
Pharmaceutical company that manufactures and markets ethical drugs.
Launch date
Employees
Market cap
€2.8b
Enterprise valuation
€1.1b (Public information from Sep 2024)
Share price
JPY5081 9987.T
Japan (HQ)
Financials
Estimates*
JPY | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|
Revenues | 2.1t | 2.2t | 2.3t | 2.4t | 2.4t | 2.4t | 2.5t |
% growth | (4 %) | 5 % | 4 % | 3 % | 1 % | 2 % | 1 % |
EBITDA | 28.5b | 33.0b | 45.1b | 47.0b | 40.3b | 42.4b | 43.0b |
% EBITDA margin | 1 % | 1 % | 2 % | 2 % | 2 % | 2 % | 2 % |
Profit | 7.9b | 14.4b | 20.3b | 29.0b | 26.5b | 22.4b | 23.0b |
% profit margin | - | 1 % | 1 % | 1 % | 1 % | 1 % | 1 % |
EV / revenue | 0.1x | 0.1x | 0.0x | 0.1x | 0.2x | 0.2x | 0.2x |
EV / EBITDA | 6.1x | 3.6x | 1.9x | 2.5x | 9.9x | 9.4x | 9.3x |
Source: Dealroom estimates
Date | Investors | Amount | Round |
---|---|---|---|
N/A | N/A | IPO | |
Total Funding | - |
Recent News about Suzuken
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.